First-line Chemotherapy in Combination With Oral Recombinant Methioninase and a Low-methionine Diet for a Stage IV Inoperable Pancreatic-Cancer Patient Resulted in 40% Tumor Reduction and an 86% CA19-9 Biomarker Decrease.
Motokazu SatoQinghong HanChihiro HozumiHideo KujiraokaKohei MizutaSei MorinagaByung Mo KangNoritoshi KobayashiYasushi IchikawaAtsushi NakajimaRobert M HoffmanPublished in: Anticancer research (2024)
Methionine restriction consisting of o-rMETase and a low-methionine diet, in combination with first-line chemotherapy, was highly effective in a patient with inoperable stage IV pancreatic cancer.